Skip to main content

Day: May 22, 2020

Choice Broking Launched Refer and Earn Referral Program

Mumbai, MH: Team Jiffy while on an innovation overdrive understands that “word-of-mouth” still remains the most reliable forms of marketing. To this end, they have introduced ‘Refer & Earn’ referral program. In this program, you can invite your friends and relatives to take-up jiffy as a trading/investing platform and earn 10% of the brokerage they generate, for their entire trading/investing sting with Jiffy. You also pocket Rs.100 incentive per referral. Your referred friend or relative gets a 10% discount on brokerage for the first 3 months. To take advantage of this offer, * Share the referral link with your friend* Your friend registers using the Referral Link or Referral ID (Client Code)* On successful account activation, you and your friends will be eligible for the ‘Refer and Earn’ program To be a part of this program there...

Continue reading

Elite Capital International: U.S. stocks fluctuating while Oil prices advances; market wraps up

Coronavirus pandemic still has no possible cure or vaccine, most people are still afraid to go out ‘cause confirmed cases keeps rising. Reason why most businesses are still close and stocks markets are still in chaos, however, governments globally are helping their economy to move forward, trying to adapt the ‘new normal’ even one small step at a time. Stocks in the U.S. fluctuate as market wraps up Thursday closing. The fluctuation is due to rapid loss of jobs and investors fear that economy will dive down more on the coming days. Bonds however are down alongside European currencies. Japanese yen on the other hand has strengthened. Commodities have made quite an impression on today’s market closing. Oil prices are up and Gold made a lead, which gave investors a good day. Stocks/Futures– NASDAQ Composite Index is down by 1.55% to...

Continue reading

Investam-HK: U.S. Treasures climbs, Oil prices keep moving and Dollar is down as market wraps up

As coronavirus confirmed cases keeps rising up as days pass by, economy worldwide are keeping their pace so not to fall to deep. Cases arise as it totals to 4.2 million to date and U.S. is the major contributor, with as of the moment has a total of 1.4 million total coronavirus confirmed cases. As to U.S. markets, most treasuries rose a bit this market day. Equities advanced after sliding a few from yesterday’s market, but dollar quite fell. Stocks / Equities– Futures on the S&P 500 Index climbed 0.6% as of 6:35 a.m. New York time.– Nasdaq 100 Index futures increased 0.7%.– The Stoxx Europe 600 Index fell 1.2%.– The MSCI All-Country World Index fell 0.2%.– The Dow Jones Industrial Average fell 457 points, 1.89%, its worst daily performance since May 1.Bonds / Treasuries– The yield on 10-year Treasuries...

Continue reading

Forge a Pandemic-Proof Financial Strategy with Goldstone Financial Group

Wednesday May 20, 2020 Oakbrook Terrace, IL: In the current unstable financial state that we all find ourselves in, many investors are worrying where and how best to devise a path out of the crisis & recession while remaining sure of their cash reserves. At Goldstone Financial Group, headed up by co founder Mr Anthony Pellegrino, their advisers are helping many clients plan cast-iron strategies to future-proof their investments and take out the uncertainty when the markets emerge post-pandemic. For those looking to benefit from the US government’s stimulus, those that can apply either have to be either single tax filers under $99,000 or for married couples, which combined have under $198,000. Anthony Pellegrino revealed that if the money was not required now, clients could invest tax-free in a Roth IRA, an individual retirement...

Continue reading

Orphazyme’s arimoclomol receives US Fast Track Designation in Amyotrophic Lateral Sclerosis

Orphazyme A/SCompany announcement                                                                                       No. 33/2020                                                                                                          Company Registration No. 32266355Copenhagen, Denmark, May 22, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, announces that the Company has received Fast Track Designation from the US Food and Drug Administration (FDA) for the development of arimoclomol for the treatment of Amyotrophic Lateral Sclerosis (ALS).Kim Stratton, Chief Executive Officer, said, “This is the third Fast Track Designation that arimoclomol has received from the FDA, which further underlines the potential of our investigational...

Continue reading

THE COMBINED GENERAL MEETING OF 12 JUNE 2020

PRESS RELEASEMAISONS DU MONDE:PROCEDURES FOR THE PARTICIPATION AND AVAILABILITY OR CONSULTATION OF PREPARATORY DOCUMENTS OFTHE COMBINED GENERAL MEETING OF 12 JUNE 2020BEING HELD BEHIND CLOSED DOORSNantes, 22 May 2020Maisons du Monde (Euronext Paris: MDM, Code ISIN: FR0013153541) announces that the Combined General Meeting (annual and extraordinary ordinary) of its shareholders will be held behind closed doors (i.e., shareholder physical presence not allowed) on Friday, 12 June 2020 at 15:00 CET, 55, Rue d’Amsterdam 75008 Paris, France.In this exceptional context, shareholders are requested to not ask for an admission card and must vote before the General Meeting, by correspondence or by giving a voting proxy to the President. Shareholders may also retain the possibility of being represented by a third party who may address his or...

Continue reading

ASSEMBLÉE GÉNÉRALE MIXTE DU 12 JUIN 2020

COMMUNIQUÉ DE PRESSEMAISONS DU MONDE :ASSEMBLÉE GÉNÉRALE MIXTE DU 12 JUIN 2020 A HUIS CLOSMODALITÉS DE PARTICIPATION ET DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PREPARATOIRESNantes, 22 mai 2020Maisons du Monde (Euronext Paris : MDM, Code ISIN : FR0013153541) annonce que l’Assemblée générale mixte (ordinaire annuelle et extraordinaire) de ses actionnaires se tiendra à huis clos (hors la présence physique des actionnaires) le vendredi 12 juin 2020 à 15 heures, 55, Rue d’Amsterdam 75008 Paris.Dans ce contexte exceptionnel, les actionnaires sont invités à ne pas demander de carte d’admission et devront voter avant la tenue de l’Assemblée générale à distance, par correspondance ou en donnant un mandat de vote au Président. Ils conservent également la possibilité de se faire représenter par un tiers qui devra adresser ses instructions...

Continue reading

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the futureRoche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect diseaseThis investment complements the development of Roche’s nanopore technology with the goal of an end-to-end sequencing solution starting from a patient sample to a diagnostic resultBasel, 22 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry,...

Continue reading

Martela’s co-operation negotiations are completed

Martela’s co-operation negotiations for lay-offs are completed. The co-operation negotiations concerned the whole Martela Group personnel in Finland. The scope and duration of lay-offs can vary by functions and regions, taking into account the business needs. The lay-offs can be implemented until the end of June 2021, if the market situation so requires.The co-operation negotiations were based on the crisis caused by the coronavirus pandemic, the long-standing uncertain market situation and the need to prepare for the possible expansion of the negative business impacts due to these factors.The Martela Group employs approximately 380 people in Finland.Martela CorporationMatti RantaniemiCEOFurther informationMatti Rantaniemi, CEO, tel. +358 50 465 8194Kalle Lehtonen, CFO, tel. +358 400 539 968DistributionNASDAQ HelsinkiMain news mediawww.martela.comOur...

Continue reading

Martelan yhteistoimintaneuvottelut ovat päättyneet

Martelan lomautuksia koskevat yhteistoimintaneuvottelut ovat päättyneet. Neuvottelut koskivat koko Martela-konsernin Suomen henkilöstöä. Lomautustarve ja kesto voivat vaihdella toiminnoittain ja alueittain liiketoimitatarpeet huomioiden. Lomautuksia voidaan toteuttaa kesäkuun 2021 loppuun saakka markkinatilanteen sitä edellyttäessä.Yhteistoimintaneuvotteluiden perusteena oli koronaviruspandemian aiheuttama poikkeustila, pitkään epävarmana jatkunut markkinatilanne sekä näistä tekijöistä johtuva tarve varautua negatiivisten vaikutusten mahdolliseen laajentumiseen liiketoiminnassa.Martela-konsernin palveluksessa Suomessa on noin 380 työntekijää.Martela OyjMatti RantaniemiToimitusjohtajaLisätiedotToimitusjohtaja Matti Rantaniemi, puh. + 358 50 465 8194Talousjohtaja Kalle Lehtonen, puh. +358 400 539 968JakeluNASDAQ HelsinkiKeskeiset tiedotusvälineetwww.martela.comMissiomme...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.